Publications for Sarah Lord
Publications for Sarah Lord
2016
Khemka, A., Lord, S., Doyle, Z., Bosley, B., Al
Muderis, M. (2016). Minimally invasive medial
patellofemoral ligament reconstruction for
patellar instability using an artificial ligament: A
two year follow-up. The Knee, 23(2), 261-266.
<a
href="http://dx.doi.org/10.1016/j.knee.2015.07.0
02">[More Information]</a>
Khemka, A., FarajAllah, C., Lord, S., Bosley, B.,
Al Muderis, M. (2016). Osseointegrated total hip
replacement connected to a lower limb
prosthesis: a proof-of-concept study with three
cases. Journal of Orthopaedic Surgery and
Research, 11(1), 1-13. <a
href="http://dx.doi.org/10.1186/s13018-016-034
8-3">[More Information]</a>
Lee, C., Davies, L., Gebski, V., Lord, S., Di Leo,
A., Johnston, S., Geyer, C., Cameron, D., Press,
M., Ellis, C., Marschner, I., Simes, R., et al
(2016). Serum human epidermal growth factor 2
extracellular domain as a predictive biomarker
for lapatinib treatment efficacy in patients with
advanced breast cancer. Journal of Clinical
Oncology, 34(9), 936-944. <a
href="http://dx.doi.org/10.1200/JCO.2015.62.47
67">[More Information]</a>
2015
Lam, J., Lord, S., Hunter, K., Simes, R., Vu, T.,
Askie, L. (2015). Australian clinical trial activity
and burden of disease: an analysis of registered
trials in National Health Priority Areas. Medical
Journal of Australia, 203(2), 97-102. <a
href="http://dx.doi.org/10.5694/mja14.00598">[
More Information]</a>
Lee, C., Goldstein, D., Gibbs, E., Joensuu, H.,
Zalcberg, J., Verweij, J., Casali, P., Maki, R.,
Cioffi, A., Lord, S., et al (2015). Development
and validation of prognostic nomograms for
metastatic gastrointestinal stromal tumour treated
with imatinib. European Journal of Cancer,
51(7), 852-860. <a
href="http://dx.doi.org/10.1016/j.ejca.2015.02.01
5">[More Information]</a>
Fisher, O., Levert-Mignon, A., Lord, S., Botelho,
N., Freeman, A., Thomas, M., Falkenback, D.,
Wettstein, A., Whiteman, D., Bobryshev, Y., et
al (2015). High Expression of Cathepsin E in
Tissues but Not Blood of Patients with Barrett's
Esophagus and Adenocarcinoma. Annals of
Surgical Oncology, 22(7), 2431-2438. <a
href="http://dx.doi.org/10.1245/s10434-014-415
5-y">[More Information]</a>
Lee, C., Lord, S., Grunewald, T., Gebski, V.,
Hardy-Bessard, A., Sehouli, J., Woie, K.,
Heywood, M., Schauer, C., Vergote, I., et al
(2015). Impact of secondary cytoreductive
surgery on survival in patients with platinum
sensitive recurrent ovarian cancer: Analysis of
the CALYPSO trial. Gynecologic Oncology,
136(1), 18-24. <a
href="http://dx.doi.org/10.1016/j.ygyno.2014.09.
017">[More Information]</a>
Lee, C., Wu, Y., Ding, P., Lord, S., Inoue, A.,
Zhou, C., Mitsudomi, T., Rosell, R., Pavlakis,
N., Links, M., Gebski, V., et al (2015). Impact of
Specific Epidermal Growth Factor Receptor
(EGFR) Mutations and Clinical Characteristics
on Outcomes After Treatment With EGFR
Tyrosine Kinase Inhibitors Versus
Chemotherapy in EGFR-Mutant Lung Cancer: A
Meta-Analysis. Journal of Clinical Oncology,
33(17), 1958-1965. <a
href="http://dx.doi.org/10.1200/JCO.2014.58.17
36">[More Information]</a>
Fisher, O., Levert-Mignon, A., Lord, S., Lee-Ng,
K., Botelho, N., Falkenback, D., Thomas, M.,
Bobryshev, Y., Whiteman, D., Brown, D., et al
(2015). MIC-1/GDF15 in Barrett's oesophagus
and oesophageal adenocarcinoma. British
Journal of Cancer, 112(8), 1384-1391. <a
href="http://dx.doi.org/10.1038/bjc.2015.100">[
More Information]</a>
Khemka, A., Frossard, L., Lord, S., Bosley, B.,
Al Muderis, M. (2015). Osseointegrated total
knee replacement connected to a lower limb
prosthesis: 4 cases. Acta Orthopaedica, 86(6),
740-744. <a
href="http://dx.doi.org/10.3109/17453674.2015.
1068635">[More Information]</a>
Horvath, A., Bossuyt, P., Sandberg, S., St John,
A., Monaghan, P., Verhagen-Kamerbeek, W.,
Lennartz, L., Cobbaert, C., Ebert, C., Lord, S.
(2015). Setting analytical performance
specifications based on outcome studies - is it
possible? Clinical Chemistry and Laboratory
Medicine, 53(6), 841-848. <a
href="http://dx.doi.org/10.1515/cclm-2015-0214
">[More Information]</a>
Nguyen, H., Lim, W., Craig, J., Chapman, J.,
Lord, S., Howard, K., Wong, G. (2015). The
Relative Benefits and Costs of Solid Phase Bead
Technology to Detect Preformed Donor Specific
Antihuman
Leukocyte Antigen Antibodies in Determining
Suitability for Kidney Transplantation.
Transplantation, 99(5), 957-964. <a
href="http://dx.doi.org/10.1097/TP.00000000000
00697">[More Information]</a>
2014
Than, M., Aldous, S., Lord, S., Goodacre, S.,
Frampton, C., Troughton, R., George, P.,
Publications for Sarah Lord
Florkowski, C., Ardagh, M., Smyth, D., et al
(2014). A 2-Hour Diagnostic Protocol for
Possible Cardiac Chest Pain in the Emergency
Department: A Randomized Clinical Trial.
JAMA Internal Medicine, 174(1), 51-58. <a
href="http://dx.doi.org/10.1001/jamainternmed.2
013.11362">[More Information]</a>
Barz, T., Melloh, M., Lord, S., Kasch, R., Merk,
H., Staub, L. (2014). A conceptual model of
compensation/decompensation in lumbar
segmental instability. Medical Hypotheses,
83(3), 312-316. <a
href="http://dx.doi.org/10.1016/j.mehy.2014.06.
003">[More Information]</a>
Barz, T., Staub, L., Melloh, M., Hamann, G.,
Lord, S., Chatfield, M., Bossuyt, P., Lange, J.,
Merk, H. (2014). Clinical validity of the nerve
root sedimentation sign in patients with
suspected lumbar spinal stenosis. The Spine
Journal, 14(4), 667-674. <a
href="http://dx.doi.org/10.1016/j.spinee.2013.06.
105">[More Information]</a>
Horvath, A., Lord, S., StJohn, A., Sandberg, S.,
Cobbaert, C., Lorenz, S., Monaghan, P.,
Verhagen-Kamerbeek, W., Ebert, C., Bossuyt, P.
(2014). From biomarkers to medical tests: The
changing landscape of test evaluation. Clinica
Chimica Acta, 427, 49-57. <a
href="http://dx.doi.org/10.1016/j.cca.2013.09.01
8">[More Information]</a>
Barz, T., Melloh, M., Staub, L., Lord, S., Lange,
J., Merk, H. (2014). Increased intraoperative
epidural pressure in lumbar spinal stenosis
patients with a positive nerve root sedimentation
sign. European Spine Journal, 23(5), 985-990.
<a
href="http://dx.doi.org/10.1007/s00586-013-307
1-3">[More Information]</a>
Tjokrowidjaja, A., Lee, C., Houssami, N., Lord,
S. (2014). Metastatic breast cancer in young
women: a population-based cohort study to
describe risk and prognosis. Internal Medicine
Journal, 44(8), 764-770. <a
href="http://dx.doi.org/10.1111/imj.12481">[Mo
re Information]</a>
2013
Campbell, L., Novak, I., McIntyre, S., Lord, S.
(2013). A KT intervention including the
evidence alert system to improve clinician's
evidence-based practice behavior-a cluster
randomized controlled trial. Implementation
Science, 8(1), 1-15. <a
href="http://dx.doi.org/10.1186/1748-5908-8-13
2">[More Information]</a>
Lee, C., Simes, R., Brown, C., Gebski, V.,
Pfisterer, J., Swart, A., Berton-Rigaud, D.,
Plante, M., Skeie-Jensen, T., Vergote, I., Lord,
S., et al (2013). A prognostic nomogram to
predict overall survival in patients with
platinum-sensitive recurrent ovarian cancer.
Annals of Oncology, 24(4), 937-943. <a
href="http://dx.doi.org/10.1093/annonc/mds538"
>[More Information]</a>
Melloh, M., Lord, S., Staub, L., Merk, H., Barz,
T. (2013). Letters. Spine, 38(11), 968. <a
href="http://dx.doi.org/10.1097/BRS.0b013e318
27e8ecd">[More Information]</a>
Fox, P., Hudson, M., Brown, C., Lord, S.,
Gebski, V., de Souza, P., Lee, C. (2013).
Markers of systemic inflammation predict
survival in patients with advanced renal cell
cancer. British Journal of Cancer, 109(1),
147-153. <a
href="http://dx.doi.org/10.1038/bjc.2013.300">[
More Information]</a>
Martin, A., Lord, S., Verry, H., Stockler, M.,
Emery, J. (2013). Risk assessment to guide
prostate cancer screening decisions: a
cost-effectiveness analysis. Medical Journal of
Australia, 198(10), 546-550. <a
href="http://dx.doi.org/10.5694/mja12.11597">[
More Information]</a>
2012
Walter, S., Macaskill, P., Lord, S., Irwig, L.
(2012). Effect of dependent errors in the
assessment of diagnostic or screening test
accuracy when the reference standard is
imperfect. Statistics in Medicine, 31(11-12),
1129-1138. <a
href="http://dx.doi.org/10.1002/sim.4444">[Mor
e Information]</a>
Verry, H., Lord, S., Martin, A., Gill, G., Lee, C.,
Howard, K., Wetzig, N., Simes, R. (2012).
Effectiveness and cost-effectiveness of sentinel
lymph node biopsy compared with axillary node
dissection in patients with early-stage breast
cancer: a decision model analysis. British
Journal of Cancer, 106(6), 1045-1052. <a
href="http://dx.doi.org/10.1038/bjc.2012.62">[M
ore Information]</a>
Lew, J., Howard, K., Gertig, D., Smith, M.,
Clements, M., Nickson, C., Shi, J., Dyer, S.,
Lord, S., Creighton, P., Canfell, K., et al (2012).
Expenditure and resource utilisation for cervical
screening in Australia. BMC Health Services
Research, 12(1), 1-15. <a
href="http://dx.doi.org/10.1186/1472-6963-12-4
46">[More Information]</a>
Lord, S., Marinovich, M., Patterson, J., Wilcken,
N., Kiely, B., Gebski, V., Crossing, S., Roder,
D., Gattellari, M., Houssami, N. (2012).
Incidence of metastatic breast cancer in an
Australian population-based cohort of women
with non-metastatic breast cancer at diagnosis.
Publications for Sarah Lord
Medical Journal of Australia, 196(11), 688-692.
<a
href="http://dx.doi.org/10.5694/mja12.10026">[
More Information]</a>
Barz, T., Staub, L., Melloh, M., Lord, S. (2012).
Letters. Spine, 35(24),
E1360-2-s2.0-78649399824. <a
href="http://dx.doi.org/10.1097/BRS.0b013e318
200486e">[More Information]</a>
Staub, L., Dyer, S., Lord, S., Simes, R. (2012).
Linking the evidence: intermediate outcomes in
medical test assessments. International Journal
of Technology Assessment in Health Care, 28(1),
52-58. <a
href="http://dx.doi.org/10.1017/S026646231100
0717">[More Information]</a>
Staub, L., Lord, S., Simes, R., Dyer, S.,
Houssami, N., Chen, R., Irwig, L. (2012). Using
patient management as a surrogate for patient
health outcomes in diagnostic test evaluation.
BMC Medical Research Methodology, 12, 1-12.
<a
href="http://dx.doi.org/10.1186/1471-2288-12-1
2">[More Information]</a>
2011
Lee, C., Hudson, M., Stockler, M., Coates, A.,
Ackland, S., Gebski, V., Lord, S., Friedlander,
M., Boyle, F., Simes, R. (2011). A nomogram to
predict survival time in women starting first-line
chemotherapy for advanced breast cancer. Breast
Cancer Research and Treatment, 129(2),
467-476. <a
href="http://dx.doi.org/10.1007/s10549-011-147
1-9">[More Information]</a>
Lee, C., Gurney, H., Brown, C., Sorio, R.,
Donadello, N., Tulunay, G., Meier, W., Bacon,
M., Maenpaa, J., Petru, E., Gebski, V., Lord, S.,
Simes, R., et al (2011).
Carboplatin-paclitaxel-induced leukopenia and
neuropathy predict progression-free survival in
recurrent ovarian cancer. British Journal of
Cancer, 105(3), 360-365. <a
href="http://dx.doi.org/10.1038/bjc.2011.256">[
More Information]</a>
Staub, L., Barz, T., Melloh, M., Lord, S.,
Chatfield, M., Bossuyt, P. (2011). Clinical
validation study to measure the performance of
the Nerve Root Sedimentation Sign for the
diagnosis of lumbar spinal stenosis.
Contemporary Clinical Trials, 32(3), 470-474.
<a
href="http://dx.doi.org/10.1016/j.cct.2011.01.015
">[More Information]</a>
Lee, C., Friedlander, M., Brown, C., Gebski, V.,
Georgoulopoulos, A., Vergote, I., Pignata, S.,
Donadello, N., Schmalfeldt, B., Delva, R., Lord,
S., Simes, R., et al (2011). Early Decline in
Cancer Antigen 125 as a Surrogate for
Progression-Free Survival in Recurrent Ovarian
Cancer. Journal of the National Cancer Institute,
103(17), 1338-1342. <a
href="http://dx.doi.org/10.1093/jnci/djr282">[M
ore Information]</a>
Lee, C., Simes, R., Brown, C., Lord, S., Wagner,
U., Plante, M., Vergote, I., Pisano, C., Parma, G.,
Burges, A., Gebski, V., et al (2011). Prognostic
nomogram to predict progression-free survival in
patients with platinum-sensitive recurrent
ovarian cancer. British Journal of Cancer,
105(8), 1144-1150. <a
href="http://dx.doi.org/10.1038/bjc.2011.364">[
More Information]</a>
Lord, S., Staub, L., Bossuyt, P., Irwig, L. (2011).
Target practice: choosing target conditions for
test accuracy studies that are relevant to clinical
practice. BMJ: British Medical Journal,
343(7822), d4684-1-d4684-5. <a
href="http://dx.doi.org/10.1136/bmj.d4684">[M
ore Information]</a>
2010
Griffiths, A., Dyer, S., Lord, S., Pardy, C.,
Fraser, I., Eckermann, S. (2010). A
cost-effectiveness analysis of in-vitro
fertilization by maternal age and number of
treatment attempts. Human Reproduction, 25(4),
924-931. <a
href="http://dx.doi.org/10.1093/humrep/dep418"
>[More Information]</a>
Creighton, P., Lew, J., Clements, M., Smith, M.,
Howard, K., Dyer, S., Lord, S., Canfell, K.
(2010). Cervical cancer screening in Australia:
modelled evaluation of the impact of changing
the recommended interval from two to three
years. BMC Public Health, 10(1), 1-14. <a
href="http://dx.doi.org/10.1186/1471-2458-10-7
34">[More Information]</a>
Botelho, N., Schneiders, F., Lord, S., Freeman,
A., Tyagi, S., Nancarrow, D., Hayward, N.,
Whiteman, D., Lord, R. (2010). Gene expression
alterations in formalin-fixed, paraffin-embedded
Barrett's esophagus and esophageal
adenocarcinoma tissues. Cancer Biology and
Therapy, 10(2), 172-179. <a
href="http://www.ncbi.nlm.nih.gov/entrez/query.
fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract
&list_uids=20543560">[More Information]</a>
Lee, C., Lord, S., Stockler, M., Coates, A.,
Gebski, V., Simes, R. (2010). Historical
cross-trial comparisons for competing treatments
in advanced breast cancer - An empirical
analysis of bias. European Journal of Cancer,
46(3), 541-548. <a
href="http://dx.doi.org/10.1016/j.ejca.2009.11.01
3">[More Information]</a>
Publications for Sarah Lord
Barz, T., Melloh, M., Staub, L., Lord, S., Lange,
J., Roder, C., Theis, J., Merk, H. (2010). Nerve
Root Sedimentation Sign: Evaluation of a New
Radiological Sign in Lumbar Spinal Stenosis.
Spine, 35(8), 892-897. <a
href="http://dx.doi.org/10.1097/BRS.0b013e318
1c7cf4b">[More Information]</a>
Lee, C., Stockler, M., Coates, A., Gebski, V.,
Lord, S., Simes, R. (2010). Self-reported
health-related quality of life is an independent
predictor of chemotherapy treatment benefit and
toxicity in women with advanced breast cancer.
British Journal of Cancer, 102(9), 1341-1347. <a
href="http://dx.doi.org/10.1038/sj.bjc.6605649">
[More Information]</a>
2009
Houssami, N., Lord, S., Ciatto, S. (2009). Breast
cancer screening: emerging role of new imaging
techniques as adjuncts to mammography.
Medical Journal of Australia, 190(9), 493-498.
<a
href="http://www.ncbi.nlm.nih.gov/entrez/query.
fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract
&list_uids=19413520">[More Information]</a>
Urwyler, N., Staub, L., Beran, D., Deplazes, M.,
Lord, S., Alberio, L., Theiler, L., Greif, R.
(2009). Is perioperative point-of-care
prothrombin time testing accurate compared to
the standard laboratory test? Thrombosis and
Haemostasis, 102(4), 779-786. <a
href="http://dx.doi.org/10.1160/TH09-03-0157"
>[More Information]</a>
Brennan, M., Houssami, N., Lord, S., Macaskill,
P., Irwig, L., Dixon, J., Warren, R., Ciatto, S.
(2009). Magnetic Resonance Imaging Screening
of the Contralateral Breast in Women With
Newly Diagnosed Breast Cancer: Systematic
Review and Meta-Analysis of Incremental
Cancer Detection and Impact on Surgical
Management. Journal of Clinical Oncology,
27(33), 5640-5649. <a
href="http://dx.doi.org/10.1200/JCO.2008.21.57
56">[More Information]</a>
Lee, C., Lord, S., Coates, A., Simes, R. (2009).
Molecular biomarkers to individualise treatment:
assessing the evidence. Medical Journal of
Australia, 190(11), 631-636. <a
href="http://www.ncbi.nlm.nih.gov/entrez/query.
fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract
&list_uids=19485842">[More Information]</a>
Lord, S., Irwig, L., Bossuyt, P. (2009). Using the
principles of randomized controlled trial design
to guide test evaluation. Medical Decision
Making, 29(5), E1-E12. <a
href="http://dx.doi.org/10.1177/0272989X09340
584">[More Information]</a>
2008
Houssami, N., Ciatto, S., Macaskill, P., Lord, S.,
Warren, R., Dixon, J., Irwig, L. (2008). Accuracy
and Surgical Impact of Magnetic Resonance
Imaging in Breast Cancer Staging: Systematic
Review and Meta-Analysis in Detection of
Multifocal and Multicentric Cancer. Journal of
Clinical Oncology, 26(19), 3248-3258. <a
href="http://dx.doi.org/10.1200/JCO.2007.15.21
08">[More Information]</a>
Lord, S., Bernstein, L., Johnson, K., Malone, K.,
McDonald, J., Marchbanks, P., Simon, M.,
Strom, B., Press, M., Folger, S., et al (2008).
Breast Cancer Risk and Hormone Receptor
Status in Older Women by Parity, Age of First
birth, and Breastfeeding: a Case-Control Study.
Cancer Epidemiology, Biomarkers and
Prevention, 17(7), 1723-1730. <a
href="http://dx.doi.org/10.1158/1055-9965.EPI-0
7-2824">[More Information]</a>
Dyer, S., Levison, D., Chen, R., Lord, S.,
Blamey, S. (2008). Systematic review of the
impact of endoscopic ultrasound on the
management of patients with esophageal cancer.
International Journal of Technology Assessment
in Health Care, 24(1), 25-35. <a
href="http://dx.doi.org/10.1017/S026646230708
004X">[More Information]</a>
Lord, S., Lee, C., Simes, R. (2008). The Role of
Predictive and Prognostic Markers in Cancer.
Cancer Forum, 32(3), 139-142.
2007
Lord, S., Irwig, L., Simes, R. (2007). A
philosophical approach to diagnostic test
evaluation - In Response. Annals of Internal
Medicine, 146(10), 757-758.
Lord, S., Lei, W., Craft, P., Cawson, J., Morris,
I., Walleser, S., Griffiths, A., Parker, S.,
Houssami, N. (2007). A systematic review of the
effectiveness of magnetic resonance imaging
(MRI) as an addition to mammography and
ultrasound in screening young women at high
risk of breast cancer. European Journal of
Cancer, 43(13), 1905-1917. <a
href="http://dx.doi.org/10.1016/j.ejca.2007.06.00
7">[More Information]</a>
Griffiths, A., Marinovich, M., Barton, M., Lord,
S. (2007). Cost analysis of gamma knife
stereotactic radiosurgery. International Journal
of Technology Assessment in Health Care, 23(4),
488-494. <a
href="http://www.ncbi.nlm.nih.gov/entrez/query.
fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract
&list_uids=17937838">[More Information]</a>
Keech, A., Gebski, V., Lord, S. (2007). Multiple
analyses in clinical trials: sound science or data
dredging? In Anthony Keech, Val Gebski,
Rhana Pike (Eds.), Interpreting and reporting
Publications for Sarah Lord
clinical trials: a guide to the CONSORT
statement and the principles of randomised
controlled trials, (pp. 123-131). Sydney:
AMPCo.
Walleser, S., Griffiths, A., Lord, S., Howard, K.,
Solomon, M., Gebski, V. (2007). What is the
value of computered tomography colonography
in patients screening positive for fecal occult
blood? A systematic review and economic
evaluation. Clinical Gastroenterology and
Hepatology, 5(12), 1439-1446. <a
href="http://dx.doi.org/10.1016/j.cgh.2007.09.00
3">[More Information]</a>
2006
Walleser, S., Griffiths, A., Higgins, A., Lord, S.,
Howard, K. (2006). Computed Tomography
Colonography.
Solomon, M., Lord, S., Walleser, S. (2006).
Review: computed tomographic colonography is
accurate for medium and large colorectal polyps
and cancer. Evidence-Based Medicine, 11(5),
153-153. <a
href="http://www.ncbi.nlm.nih.gov/entrez/query.
fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract
&list_uids=17213155">[More Information]</a>
Howard, K., Lord, S., Speer, A., Gibson, R.,
Padbury, R., Kearney, B. (2006). Value of
magnetic resonance cholangiopancreatography in
the diagnosis of biliary abnormalities in
postcholecystectomy patients: a probabilistic
cost-effectiveness analysis of diagnostic
strategies. International Journal of Technology
Assessment in Health Care, 22(1), 109-118. <a
href="http://www.ncbi.nlm.nih.gov/entrez/query.
fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract
&list_uids=16673687">[More Information]</a>
Lord, S., Irwig, L., Simes, R. (2006). When is
measuring sensitivity and specificity sufficient to
evaluate a diagnostic test, and when do we need
randomized trials? Annals of Internal Medicine,
144(11), 850-855. <a
href="http://www.ncbi.nlm.nih.gov/entrez/query.
fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract
&list_uids=16754927">[More Information]</a>
2005
Lord, S., Howard, K., Allen, F., Marinovich, M.,
Burgess, D., King, R., Atherton, J. (2005). A
systematic review and economic analysis of
drug-eluting coronary stents available in
Australia. Medical Journal of Australia, 183(9),
464-71. <a
href="http://www.ncbi.nlm.nih.gov/entrez/query.
fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract
&list_uids=16274347">[More Information]</a>
Lord, S., Howard, K. (2005). Magnetic
resonance cholangiopancreatography (MRCP).
Lord, S., Mack, W., Van Den Berg, D., Pike, M.,
Ingles, S., Haiman, C., Wang, W., Parisky, Y.,
Hodis, H., Ursin, G. (2005). Polymorphisms in
genes involved in estrogen and progesterone
metabolism and mammographic density changes
in women randomized to postmenopausal
hormone therapy. Results from a pilot study.
Breast Cancer Research, 7(3), R336-R344. <a
href="http://www.ncbi.nlm.nih.gov/entrez/query.
fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract
&list_uids=15987428">[More Information]</a>
Ursin, G., Bernstein, M., Lord, S., Karim, R.,
Deapen, D., Press, M., Dalinq, J., Norman, S.,
Liff, J., Marchbanks, P., et al (2005).
Reproductive factors and subtypes of breast
cancer defined by hormone receptor and
histology. British Journal of Cancer, 93(3),
364-371. <a
href="http://www.ncbi.nlm.nih.gov/entrez/query.
fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract
&list_uids=16079783">[More Information]</a>
Allen, F., Lord, S., Walleser, S., Howard, K.,
Higgins, A. (2005). SIR-Spheres for the
treatment of non-resectable liver tumours.
2004
Lord, S., Ghersi, D., Gattellari, M., Wilcken, N.,
Thornton, C., Simes, J. (2004). Antitumour
Antibiotic Containing Regimens For Metastatic
Breast Cancer. Cochrane Database of Systematic
Reviews, 4(CD003367), 1-123.
Lord, S., Allen, F., Howard, K. (2004). Drug
eluting stents.
Lord, S., Gebski, V., Keech, A. (2004). Multiple
Analyses In Clinical Trials: Sound Science Or
Data Dredging? Medical Journal of Australia,
181(8), 452-454.
Ursin, G., Bernstein, L., Wang, Y., Lord, S.,
Deapen, D., Liff, J., Norman, S., Weiss, L.,
Dalinq, J., Marchbanks, P., et al (2004).
Reproductive Factors and Risk of Breast
Carcinoma in a Study of White and
African-American Women. Cancer, 101(2),
353-362. <a
href="http://dx.doi.org/10.1002/cncr.20373">[M
ore Information]</a>